Trending With Impact: RNA Modification Regulatory Proteins in Melanoma
Researchers analyzed various publicly available datasets and identified two RNA modification regulatory proteins that are... read more
May 20, 2021
Category: Oncotarget
Behind the Study: Potential Therapeutic Target in Breast Cancer Cells
Dr. John Hawse from the Mayo Clinic in Minnesota, U.S., discusses his 2017 study... read more
May 17, 2021
Tomivosertib Versus Acute Myeloid Leukemia
In the cover paper chosen for Oncotarget’s Volume 12, Issue 10, researchers investigated the... read more
May 12, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #10
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
May 11, 2021
Behind the Study: Extending Survival in Glioma Models
Dr. Gregory Riggins from Johns Hopkins University discusses his 2017 study published by Oncotarget, entitled, "... read more
May 10, 2021
Trending with Impact: Composite Score May Further Classify HCC
In this trending study, the association between IGF/CTP composite scores, overall survival, and progression-free... read more
May 7, 2021
Behind the Study: Symmetry and Symmetry Breaking in Cancer
Dr. Kenneth J. Pienta and Dr. J. James Frost describe their 2017 study published by... read more
May 3, 2021
New Analogs of Mibefradil Created as Radiosensitizers for Glioblastoma
Researchers from Yale University conducted a study to create mibefradil analogs as superior radiosensitizers in... read more
April 28, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #9
Read short summaries of the latest research published by Oncotarget.Origin: Connecticut, ... read more
April 27, 2021
Behind the Study: Prognostic Role of mir-24-3p in Breast Cancer
Researchers from NYU discuss their 2018 study published in Oncotarget, entitled, "Prognostic role of elevated... read more
April 26, 2021